SHATTUCK LABS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.59 USD | +8.28% |
|
+10.54% | +48.53% |
| Mar. 04 | Shattuck Labs, Inc. Announces Board Appointments | CI |
| Mar. 01 | Sector Update: Health Care Stocks Rising Late Afternoon | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,187 | 359.5 | 97.5 | 336.1 | 503.6 | - | - |
| Enterprise Value (EV) 1 | 2,187 | 90.71 | -63.78 | 336.1 | 503.6 | 503.6 | 503.6 |
| P/E ratio | - | -7.95 x | -0.95 x | -3.48 x | -6.07 x | -5.71 x | -4.73 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 220 x | 12 x | 150 x | 203 x | 621 x | - | - |
| EV / Revenue | 220 x | 12 x | 150 x | 203 x | 621 x | - | - |
| EV / EBITDA | - | -8.19 x | -0.97 x | -3.82 x | -5.94 x | -5.18 x | -4.35 x |
| EV / FCF | -63.6 x | -5.53 x | -0.92 x | -4.12 x | -4.89 x | -3.9 x | -2.81 x |
| FCF Yield | -1.57% | -18.1% | -109% | -24.3% | -20.5% | -25.6% | -35.5% |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 41,727 | 42,247 | 42,391 | 47,137 | 47,551 | - | - |
| Reference price 2 | 52.41 | 8.510 | 2.300 | 7.130 | 10.59 | 10.59 | 10.59 |
| Announcement Date | 3/15/21 | 3/15/22 | 2/23/23 | 2/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 9.887 | 9.934 | 30.02 | 0.652 | 1.657 | 0.8112 | - | - |
| EBITDA 1 | - | - | -43.89 | -100.3 | -87.92 | -84.74 | -97.21 | -115.8 |
| EBIT 1 | - | -36.93 | -45.27 | -103.3 | -91.96 | -90.31 | -101.6 | -141.1 |
| Operating Margin | - | -371.76% | -150.81% | -15,848.01% | -5,549.61% | -11,132.83% | - | - |
| Earnings before Tax (EBT) 1 | - | - | -44.97 | -101.9 | -87.3 | -91.64 | -108.4 | -166.6 |
| Net income 1 | - | - | -44.97 | -101.9 | -87.3 | -91.64 | -108.4 | -166.6 |
| Net margin | - | - | -149.83% | -15,635.74% | -5,268.44% | -11,297.21% | - | - |
| EPS 2 | - | - | -1.070 | -2.410 | -2.050 | -1.745 | -1.853 | -2.240 |
| Free Cash Flow 1 | - | -34.39 | -65.04 | -106.1 | -81.64 | -103 | -129 | -179 |
| FCF margin | - | -346.14% | -216.68% | -16,274.85% | -4,926.67% | -12,697.24% | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 9/18/20 | 3/15/21 | 3/15/22 | 2/23/23 | 2/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1.9 | 30.08 | - | 0.05 | 0.212 | 0.39 | 0.057 | 0.2 | 0.686 | 0.714 | 0.1828 | 0.2028 | 0.2028 | 0.2228 | - |
| EBITDA 1 | - | - | -23.69 | -26.52 | -24.3 | -25.27 | -20.65 | -20.32 | -27.58 | -17.97 | -19.9 | -20.59 | -21.58 | -22.67 | - |
| EBIT 1 | -17.58 | 9.246 | -24.17 | -27.66 | -25.23 | -26.28 | -21.66 | -22.75 | -28.6 | -18.95 | -20.96 | -21.05 | -21.91 | -22 | -19.75 |
| Operating Margin | -925.26% | 30.74% | - | -55,316% | -11,900.47% | -6,737.44% | -38,001.75% | -11,373.5% | -4,168.8% | -2,654.2% | -11,468.28% | -10,377.44% | -10,804.41% | -9,872.1% | - |
| Earnings before Tax (EBT) 1 | -17.41 | - | -24.53 | -27.37 | -24.64 | -25.41 | -20.72 | -21.35 | -27.54 | -17.69 | -21.1 | -21.5 | -22.88 | -23.55 | -19.75 |
| Net income 1 | -17.41 | - | -24.53 | -27.37 | -24.64 | -25.41 | -20.72 | -21.35 | -27.54 | -17.69 | -21.1 | -21.5 | -22.88 | -23.55 | -19.75 |
| Net margin | -916.32% | - | - | -54,742% | -11,620.28% | -6,515.64% | -36,357.89% | -10,673% | -4,014.72% | -2,477.17% | -11,542.67% | -10,601.58% | -11,283.69% | -10,570.02% | - |
| EPS 2 | -0.4100 | - | -0.5800 | -0.6500 | -0.5800 | -0.6000 | -0.4900 | -0.5000 | -0.6500 | -0.4100 | -0.4575 | -0.4400 | -0.4275 | -0.4325 | -0.4200 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 3/15/22 | 5/12/22 | 8/11/22 | 11/8/22 | 2/23/23 | 5/9/23 | 8/10/23 | 11/9/23 | 2/29/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | 269 | 161 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -34.4 | -65 | -106 | -81.6 | -103 | -129 | -179 |
| ROE (net income / shareholders' equity) | - | - | - | -45.5% | -54.4% | -71.3% | -74.9% | -47% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | - | - | 7.93 | 11.6 | - | - | - | - |
| Capex / Sales | - | - | 26.41% | 1,781.29% | - | - | - | - |
| Announcement Date | 9/18/20 | 3/15/21 | 3/15/22 | 2/23/23 | 2/29/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
10.59
USD
Average target price
15.75
USD
Spread / Average Target
+48.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +48.53% | 504M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- STTK Stock
- Financials Shattuck Labs, Inc.
